The A3 adenosine receptor induces cytoskeleton rearrangement in human astrocytoma cells via a specific action on Rho proteins

Annals of the New York Academy of Sciences

Volumn 939, Issue , 2001, Pages 63-73

  Abbracchio, Maria P ^a   Camurri, Alessandra ^a   Ceruti, Stefania ^a   Cattabeni, Flaminio ^a   Falzano, Loredana ^b   Giammarioli, Anna Maria ^b   Jacobson, Kenneth A ^c   Trincavelli, Letizia ^d   Martini, Claudia ^d   Malorni, Walter ^b   Fiorentini, Carla ^b  

^a UNIVERSITY OF MILAN   (Italy)

^b ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

^d UNIVERSITY OF PISA   (Italy)

Author keywords

A3 receptor; Adenosine; Neuroprotection; Rho proteins

Indexed keywords

1,4 DIHYDRO 2 METHYL 6 PHENYL 4 (2 PHENYLETHYNYL) 3,5 PYRIDINEDICARBOXYLIC ACID 5 BENZYL 3 ETHYL ESTER; ACTIN; ADENOSINE RECEPTOR; GUANINE NUCLEOTIDE BINDING PROTEIN; RHO FACTOR; 2 CHLORO N(6) (3 IODOBENZYL)ADENOSINE 5' N METHYLURONAMIDE; 2-CHLORO-N(6)-(3-IODOBENZYL)ADENOSINE-5'-N-METHYLURONAMIDE; ADENOSINE; ADENOSINE A3 RECEPTOR; DRUG DERIVATIVE; ENZYME INHIBITOR; GUANINE NUCLEOTIDE DISSOCIATION INHIBITOR; RHO GUANINE NUCLEOTIDE DISSOCIATION INHIBITORS;

APOPTOSIS; ASTROCYTOMA; CELL DEATH; CELL SURVIVAL; CONFERENCE PAPER; CONTROLLED STUDY; CYTOSKELETON; CYTOTOXICITY; HUMAN; HUMAN CELL; IMMUNOBLOTTING; NEUROPROTECTION; ARTICLE; DRUG EFFECT; METABOLISM;

ADENOSINE; ASTROCYTOMA; CYTOSKELETON; ENZYME INHIBITORS; GUANINE NUCLEOTIDE DISSOCIATION INHIBITORS; HUMANS; RECEPTOR, ADENOSINE A3; RECEPTORS, PURINERGIC P1;

EID: 0034743290     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2001.tb03613.x     Document Type: Conference Paper

References (31)

1. Nomenclature and classification of purinoceptors
2. 3 receptors: Pharmacological properties, species-differences and receptor functions
3. 3-selective adenosine agonists
4. 3-adenosine receptors
5. 3 adenosine receptor-selective antagonists
6. 3 receptor subtype
7. 3 receptor-mediated hypotension in the rat
8. 3-adenosine receptors: Mediation of behavioral depressant effects
9. 3 receptor stimulation and cerebral ischemia
10. 3 receptor during prolonged simulated ischemia
11. 3 antagonists
12. 3 receptors and viability of astrocytes
13. L. Studies in human astroglioma cells
14. 3 Adenosine Receptor Affects Cell Cycle Progression and Cell Growth
15. 3 receptor agonist-induced neurotoxicity in rat cerebellar granule neurons
16. 3 receptor agonists
17. Apoptosis by 2-chloro-2′-deoxy-adenosine and 2-chloro-adenosine in human peripheral blood mononuclear cells
18. Adenosine-induced cell death: Evidence for receptor-mediated signalling
19. 3 receptors in cerebral ischemia. Neuronal death, recovery, or both?
20. Brain adenosine receptors as targets for therapeutic-intervention in neurodegenerative diseases
21. Rho GTPases and the actin cytoskeleton
22. Rho GTPases and their effector proteins
23. Rho as a mediator of G-protein-coupled receptor signaling
24. 3 receptors in rat brain
25. Different susceptibilities to cell death induced by t-butylhydroperoxide could depend upon cell histotype-associated growth features
26. A chimeric toxin to study the role of the 21 kDa GTP binding protein rho in the control of actin microfilament assembly
27. Escherichia coli cytotoxic necrotizing factor 1 (CNF1), a toxin that activates the rho GTPase
28. Regulation mechanism of ERM (Erzin/Radixin/Moesin) protein/plasma membrane association: Possible involvement of phosphatidylinositol turnover and Rho-dependent signaling pathway
29. Clostridium difficile toxin B induces apoptosis in intestinal cultured cells
30. 3 receptor: Sustained cardioprotection
31. "Ischemic tolerance" phenomenon found in the brain